MARKET

NEO

NEO

Neogenomics Inc
NASDAQ
16.87
-1.29
-7.10%
After Hours: 17.04 +0.17 +1.01% 17:37 03/24 EDT
OPEN
17.75
PREV CLOSE
18.16
HIGH
17.80
LOW
16.70
VOLUME
1.56M
TURNOVER
0
52 WEEK HIGH
19.51
52 WEEK LOW
6.00
MARKET CAP
2.15B
P/E (TTM)
-14.5143
1D
5D
1M
3M
1Y
5Y
Health Care Sector Update for 03/22/2023: ETNB, ENSC, NEO
NASDAQ · 4d ago
Health Care Sector Update for 03/22/2023: ETNB, PBLA, NEO
NASDAQ · 4d ago
Sector Update: Health Care Stocks Mostly Down in Late Afternoon
Sector Update: Health Care Stocks Mostly Down in Late Afternoon
MT Newswires · 4d ago
Sector Update: Health Care Stocks Declines Wednesday Afternoon
Sector Update: Health Care Stocks Declines Wednesday Afternoon
MT Newswires · 4d ago
BRIEF-Massive Bio And Neogenomics Announce Collaboration To Accelerate Oncology Drug Discovery And Improve Patient Care
Reuters · 4d ago
NeoGenomics Enters Into Collaboration With Massive Bio to Expedite Oncology Drug Discovery
NeoGenomics Enters Into Collaboration With Massive Bio to Expedite Oncology Drug Discovery
MT Newswires · 4d ago
NeoGenomics (NEO) Initiated with a Buy at SVB Securities
TipRanks · 6d ago
NeoGenomics launches RaDaR test to detect minimal residual disease
Seeking Alpha · 03/16 11:49
More
About NEO
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories. The Company operates through two segments: the Clinical Services Segment and the Pharma Services Segment. The Clinical Services segment provides various clinical testing services to community-based pathology practices, oncology practices, hospital pathology labs, reference labs, and academic centers with reimbursement from various payers, including client direct billing, commercial insurance, Medicare and other government payers, and patients. The Pharma Services segment supports pharmaceutical firms in their drug development programs by providing testing services and data analytics for clinical trials and research. The Company offers testing services, which include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry (IHC) and digital imaging, molecular testing and morphologic analysis. It operates testing laboratories in United States, Europe and Asia.

Webull offers kinds of NeoGenomics, Inc. stock information, including NASDAQ:NEO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NEO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NEO stock methods without spending real money on the virtual paper trading platform.